One more biotech stock to watch!!# Stock
g*e
1 楼
From my blog:
http://www.mitbbs.com/pc/pccon_12673_256059.html
TSRX -- current at 4.45
It is still in down trend, it seems will go to 4. Once the share price
stable, will load.
Catalyst event:
"As with our ESTABLISH 1 study, ESTABLISH 2 was designed to prepare
tedizolid for
registration globally by capturing both the new and former FDA endpoints as
well as the
European endpoints for ABSSSI," said Jeffrey Stein, Ph.D., President and
Chief
Executive Officer at Trius. "We remain on schedule to report top-line
results from this
study in early 2013. The tedizolid clinical program reflects our commitment
to bring safe,
well-tolerated and convenient therapies to people with life-threatening
infections."
Target: $7 in 2 months
http://www.mitbbs.com/pc/pccon_12673_256059.html
TSRX -- current at 4.45
It is still in down trend, it seems will go to 4. Once the share price
stable, will load.
Catalyst event:
"As with our ESTABLISH 1 study, ESTABLISH 2 was designed to prepare
tedizolid for
registration globally by capturing both the new and former FDA endpoints as
well as the
European endpoints for ABSSSI," said Jeffrey Stein, Ph.D., President and
Chief
Executive Officer at Trius. "We remain on schedule to report top-line
results from this
study in early 2013. The tedizolid clinical program reflects our commitment
to bring safe,
well-tolerated and convenient therapies to people with life-threatening
infections."
Target: $7 in 2 months